Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
191 studies found for:    Open Studies | "Mycobacterium Infections"
Show Display Options
Rank Status Study
21 Unknown  Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
Conditions: Latent Tuberculosis Infection;   Tuberculosis Disease
Intervention:
22 Recruiting A Randomized, Placebo Controlled, Partially Blinded Phase II Study to Evaluate Safety, Immunogenicity, and Prevention of Infection With Mycobacterium Tuberculosis of AERAS-404 and BCG Revaccination in Healthy Adolescents (040-404)
Condition: Tuberculosis
Interventions: Biological: AERAS-404;   Drug: Placebo;   Biological: Bacillus Calmette-Guérin (BCG)
23 Recruiting A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida
Conditions: Cystic Fibrosis;   Pediatrics
Intervention: Biological: Sputum
24 Not yet recruiting Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
Conditions: Mansonella Perstans Infection;   Buruli Ulcer;   Tuberculosis;   Co-infection
Intervention: Drug: Doxycycline
25 Not yet recruiting Mycobacterium w in Patients With Severe Sepsis
Condition: Sepsis
Interventions: Biological: Mycobacterium w;   Other: Best standard care
26 Recruiting Bronchiectasis Research Registry
Conditions: Non-CF Bronchiectasis;   Nontuberculosis Mycobacteria (NTM)
Intervention:
27 Recruiting Phenotypic Clinical, and Genetic Characteristics of Patients With Nontuberculosis Mycobacteria
Condition: Nontuberculosis Mycobacterial Lung Disease
Intervention:
28 Unknown  Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Conditions: HIV;   AIDS;   Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB;   Drug: Deferred RV and antiMTB treatment
29 Recruiting Rituximab for Anti-cytokine Autoantibody-Associated Diseases
Conditions: Anticytokine Autoantibody-Associated Diseases;   Disseminated Non-Tuberculous Mycobacteria;   Chronic Mucocutaneous Candidiasis;   Pulmonary Alveolar Proteinosis (PAP)
Intervention: Drug: Rituximab/Rituxan
30 Recruiting Performance of IGRAs for TB Infection Diagnosis in Elderly
Conditions: Ageing;   Tuberculosis
Intervention: Other: Blood samples
31 Unknown  Establishing a Diagnostic Test for Non-tuberculous Mycobacteria Lung Infection Using Non-tuberculous Mycobacteria Antigen Stimulation Test: From Immune Base, Standardized Setup to Validation
Condition: To Set up NTM Stimulation Test Foar Diagnosing NTM Pulmonary Infectionon.
Intervention:
32 Recruiting Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis
Condition: Tuberculosis
Interventions: Drug: Vaccae;   Drug: placebo
33 Unknown  The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
Conditions: Rheumatic Disease;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Tuberculosis
Intervention:
34 Unknown  Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
Conditions: Rheumatoid Arthritis;   Spondylarthritis;   Tuberculosis
Interventions: Procedure: Quantiferon-TB Gold assay;   Procedure: Tuberculin skin test
35 Recruiting Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Ethambutol;   Drug: Rifampin;   Drug: Azithromycin;   Drug: Pancrelipase
36 Recruiting PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis
Condition: Cystic Fibrosis
Intervention:
37 Not yet recruiting Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG 50 mg;   Drug: EFV 600 mg
38 Recruiting Evaluating Diagnostics for Paediatric Tuberculosis by Blood Culture
Condition: Tuberculosis Infection
Intervention:
39 Unknown  Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children
Conditions: Tuberculosis;   HIV
Interventions: Procedure: Interferon-Gamma Release Assay;   Drug: RT-23
40 Recruiting Training Protocol on the Natural History of Tuberculosis
Condition: Tuberculosis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years